← Back to Search

Transcranial Direct Current Stimulation

Cognitive Remediation for Multiple Sclerosis

N/A
Waitlist Available
Led By Leigh Charvet, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinician Referral for cognitive remediation.
Have undergone a neurological examination and neuropsychological examination as part of standard of care.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will test whether adding electrical stimulation to cognitive training can help improve brain function in adults with deficits. Up to 100 adults will participate in the 60-session study.

Eligible Conditions
  • Multiple Sclerosis
  • Neurological Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
A doctor has recommended that you receive cognitive remediation.
Select...
You have completed a routine check-up of your brain function and thinking abilities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants completing at least 80% of the targeted number of sessions.
Secondary outcome measures
Tolerability questionnaire

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive RemediationExperimental Treatment1 Intervention
For the 20 cognitive remediation sessions, eligible participants will receive 20 minutes of active tDCS stimulation (up to 2.0 mA, dorsolateral prefrontal cortex (dlPFC) motage) while they complete the cognitive training tasks. Once the participant has completed his/her 20 sessions a pre/post treatment assessment measures will be completed.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
tDCS stimulation
2017
N/A
~20

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,798 Total Patients Enrolled
23 Trials studying Multiple Sclerosis
2,309 Patients Enrolled for Multiple Sclerosis
Leigh Charvet, MDPrincipal InvestigatorNew York University Medical Center Institutional Review Boards
7 Previous Clinical Trials
384 Total Patients Enrolled
6 Trials studying Multiple Sclerosis
363 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any participants currently being welcomed into this experiment?

"The most recent information hosted on clinicaltrials.gov proclaims that this trial is actively recruiting study participants. First posted in February of 2017 and last updated in October of 2022, the research team seeks willing volunteers for their investigation."

Answered by AI

What is the aggregate number of participants involved in this trial?

"Affirmative. Clinicaltrials.gov suggests that this research project, which first emerged on the 7th of February 2017, is currently enlisting patients. Approximately 100 individuals need to be enrolled at one trial site."

Answered by AI
~2 spots leftby Mar 2025